Answer
Raltegravir is eliminated mainly through UGT1A1-mediated glucuronidation.
Sources for this answer
- Raltegravir 600 mg film-coated tabletsLupin Healthcare (UK) Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked